JB hospital expects continued healthcare demand from Singapore MediSave patients as RTS Link nears

Regency Specialist Hospital, the sole Johor Bahru (JB) hospital currently involved in Singapore's overseas MediSave scheme, has experienced a doubling in the number of Singaporean patients utilizing MediSave since the COVID-19 pandemic. With the impending commencement of the Rapid Transit System (RTS) Link in January 2027, the hospital anticipates sustained demand from Singaporean patients seeking healthcare services.

Singaporean and Indonesian patients comprised the majority of the 150 to 200 international patients visiting the JB hospital daily, though the exact number of MediSave patients from Singapore was not disclosed. According to Channel News Asia, nine out of every ten MediSave patients at the hospital were women. Among the most frequently sought treatments were obstetrics and gynaecology services, particularly maternity care.

A 2025 study by Singapore-based think-tank ISEAS-Yusof Ishak Institute revealed that Singaporeans could save between 24% and 74% on medical procedures by having them performed in Malaysia, with in-vitro fertilisation (IVF) yielding the highest savings, at 74%. Regency Specialist Hospital CEO Serena Yong noted that Singaporeans prioritize affordability and accessibility when seeking treatment across the causeway.

While treatment costs in JB may be up to 10% higher on a dollar-for-dollar basis, the favorable exchange rate significantly mitigates this cost difference. Young emphasized that affordability, quality, safety, and the expertise of doctors remain crucial factors for patients making cross-border healthcare decisions. Since March 2010, Singaporeans and permanent residents have been eligible to use MediSave for elective hospitalisations and day surgeries at accredited healthcare facilities overseas through a clinical assessment, financial counselling, and an eligibility check by Singapore-based healthcare provider Health Management International (HMI).

Financial Alliance associate director Francis Hoan stated that cross-border healthcare is expected to become a significant supplement to Singapore's healthcare system rather than a full replacement. However, he cautioned that the longer-term impact could entail pricing pressures on Singapore healthcare providers. Additionally, a BlackBox Research survey found that nearly half of Singaporeans aged 35 to 44 anticipate shifting over S$250 in monthly spending to JB once the RTS Link begins operations.